5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis

Journal of Dermatological Science

Volumn 79, Issue 2, 2015, Pages 155-162

  Hu, Zheng ^a   Fan, Haixia ^b   Lv, Guixiang ^b   Zhou, Qi ^a   Yang, Bin ^a   Zheng, Jinhua ^b   Cao, Wenwu ^a,c  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

5 Aminolevulinic acid; Anti tumor effects; Malignant melanoma; microRNA; Positive feedback loop; Sonodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; CYCLIN D1; CYCLIN DEPENDENT KINASE 6; MICRORNA 34A; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; MICRORNA; MIRN34 MICRORNA, MOUSE; PHOTOSENSITIZING AGENT; SIRT1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SONODYNAMIC THERAPY; ULTRASOUND THERAPY; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; ELASTOGRAPHY; MELANOMA, EXPERIMENTAL; METABOLISM; NUDE MOUSE; PHOTOCHEMOTHERAPY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

AMINOLEVULINIC ACID; ANIMALS; CELL LINE, TUMOR; ELASTICITY IMAGING TECHNIQUES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MODELS, ANIMAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53; ULTRASONIC THERAPY;

EID: 84955721468     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2015.04.010     Document Type: Article

References (45)

1. Eggermont A.M., Spatz A., Robert C. Cutaneous melanoma. Lancet 2014, 383:816-827.
2. Gray-Schopfer V., Wellbrock C., Marais R. Melanoma biology and new targeted therapy. Nature 2007, 445:851-857.
3. Saleem M., Maddodi N., Abu Zaid M., Khan N., bin Hafeez B., Asim M., et al. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res 2008, 14:2119-2127.
4. Trendowski M. The promise of sonodynamic therapy. Cancer Metastasis Rev 2014, 33:143-160.
5. Arakawa K., Hagisawa K., Kusano H., Yoneyama S., Kurita A., Arai T., et al. Sonodynamic therapy decreased neointimal hyperplasia after stenting in the rabbit iliac artery. Circulation 2002, 105:149-151.
6. Hasanzadeh H., Mokhtari-Dizaji M., Bathaie S.Z., Hassan Z.M., Nilchiani V., Goudarzi H. Enhancement and control of acoustic cavitation yield by low-level dual frequency sonication: a subharmonic analysis. Ultrason Sonochem 2011, 18:394-400.
7. Tsuru H., Shibaguchi H., Kuroki M., Yamashita Y., Kuroki M. Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer. Free Radic Biol Med 2012, 53:464-472.
8. Yumita N., Iwase Y., Nishi K., Komatsu H., Takeda K., Onodera K., et al. Involvement of reactive oxygen species in sonodynamically induced apoptosis using a novel porphyrin derivative. Theranostics 2012, 2:880-888.
9. Krammer B., Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 2008, 7:283-289.
10. Lv Y.H., Fang M., Zheng J.H., Yang B., Li H.X., Zhong X.Z.G., et al. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol Biochem 2012, 30:321-333.
11. Ohmura T., Fukushima T., Shibaguchi H., Yoshizawa S., Inoue T., Kuroki M., et al. Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat. Anticancer Res 2011, 31:2527-2533.
12. Jeong E.J., Seo S.J., Ahn Y.J., Choi K.H., Kim K.H., Kim J.K. Sonodynamically induced antitumor effects of 5-aminolevulinic acid and fractionated ultrasound irradiation in an orthotopic rat glioma model. Ultrasound Med Biol 2012, 38:2143-2150.
13. Song W., Cui H.D., Zhang R., Zheng J.H., Cao W.W. Apoptosis of SAS cells induced by sonodynamic therapy using 5-aminolevulinic acid sonosensitizer. Anticancer Res 2011, 31:39-45.
14. Gao Z.X.Z., Zheng J.H., Yang B., Wang Z., Fan H.X., Lv Y.H., et al. Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model. Cancer Lett 2013, 335:93-99.
15. Li Y.J., Huang P., Jiang C.L., Jia de X., Du X.X., Zhou J.H., et al. Sonodynamically induced anti-tumor effect of 5-aminolevulinic acid on pancreatic cancer cells. Ultrasound Med Biol 2014, 40:2671-2679.
16. Lujambio A., Lowe S.W. The microcosmos of cancer. Nature 2012, 482:347-355.
17. Mendell J.T., Olson E.N. MicroRNAs in stress signaling and human disease. Cell 2012, 148:1172-1187.
18. Ebert M.S., Sharp P.A. Roles for microRNAs in conferring robustness to biological processes. Cell 2012, 149:515-524.
19. Friedman R.C., Farh K.K.H., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
20. Sun V., Zhou W.B., Majid S., Kashani-Sabet M., Dar A.A. MicroRNA-mediated regulation of melanoma. Br J Dermatol 2014, 171:234-241.
21. Gaziel-Sovran A., Segura M.F., Di Micco R., Collins M.K., Hanniford D., Vega-Saenz de Miera E., et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 2011, 20:104-118.
22. He L., He X.Y., Lim L.P., De Stanchina E., Xuan Z.Y., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
23. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007, 26:731-743.
24. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752.
25. Hermeking H. p53 enters the MicroRNA world. Cancer Cell 2007, 12:414-418.
26. Li H.X., Fan H.X., Wang Z., Zheng J.H., Cao W.W. Potentiation of Scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound. PLOS ONE 2013, 8.
27. Lv G., Hu Z., Tie Y., Du J., Fu H., Gao X., et al. MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration. Oncol Rep 2014, 32:1021-1028.
28. Yamakuchi M., Ferlito M., Lowenstein C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 2008, 105:13421-13426.
29. Li L.S., Yuan L.J., Luo J.M., Gao J., Guo J.L., Xie X.M. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 2013, 13:109-117.
30. Sun F., Fu H.J., Liu Q., Tie Y., Zhu J., Xing R.Y., et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008, 582:1564-1568.
31. Yan D., Dong X.D., Chen X., Yao S., Wang L., Wang J., et al. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS ONE 2012, 7:e40967.
32. Schultz J., Lorenz P., Gross G., Ibrahim S., Kunz M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 2008, 18:549-557.
33. Chen X., Wang J., Shen H., Lu J., Li C., Hu D.N., et al. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Investig Ophthalmol Vis Sci 2011, 52:1193-1199.
34. Noguchi S., Mori T., Otsuka Y., Yamada N., Yasui Y., Iwasaki J., et al. Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J Biol Chem 2012, 287:11769-11777.
35. Heinemann A., Zhao F., Pechlivanis S., Eberle J., Steinle A., Diederichs S., et al. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res 2012, 72:460-471.
36. Su X., Wang P., Yang S., Zhang K., Liu Q., Wang X. Sonodynamic therapy induces the interplay between apoptosis and autophagy in K562 cells through ROS. Int J Biochem Cell Biol 2015, 60C:82-92.
37. Wang P., Wang X.B., Zhang K., Gao K.L., Song M., Liu Q.H. The spectroscopy analyses of PpIX by ultrasound irradiation and its sonotoxicity in vitro. Ultrasonics 2013, 53:935-942.
38. Li Y.X., Wang P., Zhao P., Zhu S.J., Wang X.B., Liu Q.H. Apoptosis induced by sonodynamic treatment by protoporphyrin IX on MDA-MB-231 cells. Ultrasonics 2012, 52:490-496.
39. Wang X.B., Liu Q.H., Mi N., Wang P., Tang W., Zhao X.H., et al. Sonodynamically induced apoptosis by protoporphyrin IX on hepatoma-22 cells in vitro. Ultrasound Med Biol 2010, 36:667-676.
40. Liang L., Xie S., Jiang L., Jin H., Li S.G., Liu J.W. The combined effects of hematoporphyrin monomethyl ether-SDT and doxorubicin on the proliferation of QBC939 Cell Lines. Ultrasound Med Biol 2013, 39:146-160.
41. Tang W., Fan W.Y., Liu Q.H., Zhang J., Qin X.F. The role of p53 in the response of tumor cells to sonodynamic therapy in vitro. Ultrasonics 2011, 51:777-785.
42. Yan D., Zhou X., Chen X., Hu D.N., Dong X.D., Wang J., et al. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Investig Ophthalmol Vis Sci 2009, 50:1559-1565.
43. Lodygin D., Tarasov V., Epanchintsev A., Berking C., Knyazeva T., Korner H., et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
44. Lee J.T., Gu W.S.I.R.T. Regulator of p53 deacetylation. Genes Cancer 2013, 4:112-117.
45. Achanta G., Huang P. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res 2004, 64:6233-6239.